You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FENC Award Disclosure
Hackman Jeffrey S. · SEC Form 4 · Filed Aug 31, 2026
Award
Calculated transaction value
$0
Hackman Jeffrey S. Chief Executive Officer
FENC
Transaction date
Aug 31, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed same day
FENC daily price context
Close on/before transaction
$12.35
Aug 31, 2026
First close after public filing
$12.03
Sep 1, 2026
30-day return after filing
-11.47%
Through Sep 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 1,159 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001926254-26-000014
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Fennec Pharmaceuticals Inc. FENC Current | Award | Aug 31, 2026 | $0 |